Lazard Inc.’s LAZ first-quarter 2025 adjusted earnings per share of 56 cents beat the Zacks Consensus Estimate of 27 cents. However, this compared unfavorably with earnings of 66 cents per share in the year-ago quarter. Lazard’s results were positively impacted by lower operating expenses. However, a decline in revenues in the financial advisory, asset management and corporate segments alongside lower assets under management (“AUM”) balance acted as a spoilsport. In light of these negatives, shares of the company declined 3.1% on Friday’s trading session following the release of its first-quarter 2025 results. Lazard’s net income (GAAP) was $60.4 million, which jumped 68.9% from the prior-year quarter's level. Lazard’s Revenues Decrease Y/Y Quarterly operating revenues were $643.2 million, which declined 13.8% year over year. Nonetheless, the top line surpassed the Zacks Consensus Estimate of $616 million. Lazard’s Expenses Down Operating expenses were $593.4 million, down 16.4% year over year. The ratio of adjusted compensation expenses to operating revenues was 65.5, down from the year-earlier quarter’s 66. The ratio of adjusted non-compensation expenses to operating revenues was 23, up from the year-ago quarter’s 18. Lazard’s Segmental Performance Financial Advisory: The segment’s adjusted operating revenues were $369.5 million, down 17.3% from the year-earlier quarter. Asset Management: Segmental adjusted operating revenues of $264.5 million decreased 4.1% from the prior-year quarter. Corporate: Adjusted operating revenues from this segment were $9.1 million, down 61.9% from the year-earlier quarter. LAZ’s AUM Declines As of March 31, 2025, the total AUM was $227.4 billion, which decreased 9.2% from the prior-year quarter. LAZ’s first quarter witnessed a market appreciation of $0.8 billion, foreign exchange appreciation of $3.9 billion and net outflows of $3.7 billion. The average AUM in the reported quarter was $230.8 billion, down 6.5% year over year. Lazard’s Balance Sheet Position Weakens The company’s cash and cash equivalents totaled $908.6 million as of March 31, 2025, down 30.5% from the prior quarter. Stockholders’ equity was $648.6 million, down 5.3% sequentially. LAZ’s Share Repurchase Update In the reported quarter, Lazard repurchased 0.8 million shares at an average price of $46.73 per share. As of March 31, 2025, roughly $164 million of authorization remained available for repurchase. Our View on LAZ Lazard’s increased dependence on advisory revenues and continued net outflows will affect its top-line growth in the upcoming period. Nonetheless, innovative investment strategies and strategic initiatives to mitigate costs will help profitability. However unfavorable debt/equity ratio will likely make capital distributions unsustainable. Story Continues Lazard, Inc. Price, Consensus and EPS SurpriseLazard, Inc. Price, Consensus and EPS Surprise Lazard, Inc. price-consensus-eps-surprise-chart | Lazard, Inc. Quote Currently, Lazard carries a Zacks Rank #5 (Strong Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Performances of Other Asset Managers Invesco’s IVZ first-quarter 2025 adjusted earnings of 44 cents per share surpassed the Zacks Consensus Estimate of 39 cents. Moreover, the bottom line jumped 33.3% from the prior-year quarter. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) IVZ’s results were primarily aided by higher adjusted net revenues. An increase in the AUM balance due to decent inflows was positive too. However, higher adjusted operating expenses were woe. BlackRock’s BLK first-quarter 2025 adjusted earnings of $11.30 per share handily surpassed the Zacks Consensus Estimate of $10.43. The figure reflects a rise of 15% from the year-ago quarter. BLK’s results benefited from a rise in revenues. AUM witnessed robust growth and touched a record high of $11.58 trillion, driven by net inflows and favorable forex impact, partially offset by market depreciation. However, higher expenses and lower non-operating income were headwinds. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report BlackRock (BLK):Free Stock Analysis Report Invesco Ltd. (IVZ):Free Stock Analysis Report Lazard, Inc. (LAZ):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Lazard's Q1 Earnings Beat Estimates on Y/Y Lower Expenses, Stock Down
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...